1. Sofosbuvir-based therapy for genotype 4 HCV recurrence post-liver transplant treatment-experienced patients;Ajlan;Chin. J. Gastroenterol. Hepatol.,2016
2. Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes;Borgia;J. Infect. Dis.,2018
3. Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection;Bourliere;N. Engl. J. Med.,2017
4. Resistance Analyses for Ledipasvir/Sofosbuvir-Containing Regimens in Patients Infected with Chronic HCV Who Have Advanced Liver Disease or Are Post Liver Transplant (SOLAR-1 and -2 Studies) the International Liver Congress;Charlton,2016
5. Nucleotide inhibitor resistance selections using GT2a infectious virus: PSI-7851 and GS-6620 select for a novel resistance pathway including substitutions of M289V/L followed by S282T;Cheng,2011